يعرض 1 - 20 نتائج من 179 نتيجة بحث عن '"A. PIGAZZANI"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
  3. 3
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal

    المصدر: Mackenzie , I S , Rogers , A , Poulter , N R , Williams , B , Brown , M J , Webb , D J , Ford , I , Rorie , D , Guthrie , G , Grieve , J W K , Pigazzani , F , Rothwell , P M , Young , R , McConnachie , A , Struthers , A D , Lang , C C , MacDonald , T M 2022 , ' Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME Study) ....

    وصف الملف: application/pdf

  12. 12
    Academic Journal
  13. 13
    Academic Journal

    وصف الملف: text

    Relation: https://eprints.gla.ac.uk/284098/1/284098.pdf; Mackenzie, I. S. et al. (2022) Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet , 400(10361), pp. 1417-1425. (doi:10.1016/S0140-6736(22)01786-X ) (PMID:36240838) (PMCID:PMC9631239)

  14. 14
    Academic Journal
  15. 15
    Academic Journal

    مصطلحات موضوعية: RM Therapeutics. Pharmacology

    Relation: Pigazzani, F., Dyar , K. A., Morant , S. V., Vetter , C., Rogers , A., Flynn , R. W. V., Rorie , D. A., Mackenzie , I. S., Cappuccio, Francesco, Manfredini, R. and MacDonald, T. M. (2024) Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes : the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study. eClinicalMedicine . ISSN 2589-5370. (In Press)

  16. 16
    Academic Journal

    المساهمون: Y. Bruinen de Bruin, A.-. Lequarre, J. McCourt, P. Clevestig, F. Pigazzani, M. Zare Jeddi, C. Colosio, M. Goulart

    Relation: info:eu-repo/semantics/altIdentifier/pmid/32296266; info:eu-repo/semantics/altIdentifier/wos/WOS:000531901000032; volume:128; firstpage:1; lastpage:8; numberofpages:8; journal:SAFETY SCIENCE; http://hdl.handle.net/2434/732682; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85083436049

  17. 17
    Academic Journal

    المساهمون: Gobbi, G, Carubbi, C, Tagliazucchi, Gm, Masselli, E, Mirandola, P, Pigazzani, F, Crocamo, A, Notarangelo, Mf, Suma, S, Paraboschi, E, Maglietta, G, Nagalla, S, Pozzi, G, Galli, D, Vaccarezza, M, Fortina, P, Addya, S, Ertel, A, Bray, P, Duga, S, Berzuini, C, Vitale, M, Ardissino, D.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/31863085; info:eu-repo/semantics/altIdentifier/wos/WOS:000508872700020; volume:9; issue:1; numberofpages:8; journal:SCIENTIFIC REPORTS; https://hdl.handle.net/20.500.11768/154076

  18. 18
    Academic Journal
  19. 19
    Academic Journal

    وصف الملف: text

    Relation: http://eprints.gla.ac.uk/226097/3/226097.pdf; http://eprints.gla.ac.uk/226097/2/266097Suppl.pdf; Mackenzie, I. S. et al. (2020) Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet , 396(10264), pp. 1745-1757. (doi:10.1016/S0140-6736(20)32234-0 ) (PMID:33181081)

  20. 20
    Academic Journal